Sarah Kind
Papers
2
Total Citations
17
H-Index
2
About
Dr. Sarah Kind is a pioneering urologic surgeon whose work centers on advancing robotic-assisted radical prostatectomy, particularly through the adoption and refinement of single-port (SP) surgical platforms. Her major contributions address the critical learning curve and technical limitations of the da Vinci SP system, providing evidence that its implementation does not compromise oncologic outcomes. In her landmark 2021 study, she demonstrated that a prostate cancer referral center could adopt the SP platform without increasing positive surgical margins, a finding that has garnered 13 citations and helped validate this technology for broader clinical use. Dr. Kind further explores complex surgical scenarios, such as performing robotic prostatectomy in patients with prior Urolift® implants—a device for treating lower urinary tract symptoms. Her 2023 work, with 4 citations, identifies the specific anatomical distortions and inflammatory changes caused by Urolift® that challenge standard surgical landmarks, offering crucial guidance for surgeons navigating these difficult cases. Through these investigations, Dr. Kind is shaping best practices for next-generation robotic surgery, ensuring that technological innovation translates into safe, effective patient care.
Research Focus
Key Achievements
Top Papers
- 1
- 2